Pulmonology
News from the FDA/CDC
Vaping-linked injuries top 1,600 cases
Thirty-four deaths have now been confirmed.
News
ACIP approves 2020 adult vaccination schedule
Updates to ACIP adult vaccination schedule include language on shared clinical decision making.
News
ACIP plans flu review for older adults
Work group will address issues of which flu vaccine options may be best for seniors.
News
ACIP recommends two options for pertussis vaccination
Updated language allows use of either Tdap or Td for pertussis booster, prophylaxis, and catch-up immunization, according to ACIP recommendations...
News from the FDA/CDC
CDC: Don’t vape, especially THC
Conference Coverage
Recent COPD exacerbation did not affect aclidinium’s efficacy in high-risk patients
NEW ORLEANS – A history of recent exacerbations didn’t significantly affect the safety or efficacy of aclidinium bromide in patients with moderate...
News from the FDA/CDC
FDA approves Trikafta for treatment of cystic fibrosis
This drug makes treatment available to most cystic fibrosis patients, including adolescents.
News
The effect of smoking lingers
Conference Coverage
Amoxicillin/clavulanate emerges as best antibiotic for childhood bronchiectasis
MADRID – In children with nonsevere bronchiectasis, amoxicillin/clavulanate should be the first-line antibiotic.
News from the FDA/CDC
Vaping-linked lung injuries near 1,500
Seventy percent of patients are male, and 79% are under age 35 years.